Eric Lazear
Encore Pharmaceuticals (United States)
ORCID: 0000-0001-6173-8904Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “Retargeting IL-2 Signaling to NKG2D-Expressing Tumor-Infiltrating Leukocytes Improves Adoptive Transfer Immunotherapy”.
Dongge Li, Yizhan Guo, Bayan Mahgoub, Lea Paragas, Jacqueline S. Slobin +10 more
Dongge Li, Yizhan Guo, Zhongcheng Mei, Christine L. Lau, Kelly Chen +6 more
Yizhan Guo, Andrew Miller, Mika Hata, Zhongcheng Mei, Amir Manafi +11 more
Andrew E. Gelman, Ryuji Higashikubo, Alexander S. Krupnick, Daved H. Fremont, Reza Ghasemi +6 more
Laura E. Herring, Heather A. Vincent, Kyle C. Arend, Ian M. McDonald, Thomas S.K. Gilbert +7 more